Apimeds Pharmaceuticals US, Inc. (APUS NYSE MKT) stock market data APIs
$1.95
0.1(5.1%)
as of March 23, 2026
Try our APIs with
free plan!
Apimeds Pharmaceuticals US, Inc. Financial Data Overview
Price chart is built with
Anychart
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Prev. Close
1.95
Open
2.051
High
2.055
Low
1.7089
52 wk Range
0.951-4.031
Market Cap
24 523 K
Shares Outstanding
12 576 K
EPS
-0.14
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Apimeds Pharmaceuticals US, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Apimeds Pharmaceuticals US, Inc. data using free add-ons & libraries
Get Apimeds Pharmaceuticals US, Inc. Fundamental Data
Apimeds Pharmaceuticals US, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Apimeds Pharmaceuticals US, Inc. News
New
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHAN...
Apimeds Pharmaceuticals adds two key executives to leadership team
NEW YORK - Apimeds Pharmaceuticals US, Inc. (NYSE American:APUS), a clinical-stage biopharmaceutical company with a market capitalization of $21.3 million, has appointed two new executives to its lead...
Get Apimeds Pharmaceuticals US, Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
